Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) FCF Margin (2017 - 2025)

Assembly Biosciences (ASMB) has 8 years of FCF Margin data on record, last reported at 140.65% in Q3 2025.

  • For Q3 2025, FCF Margin rose 8205.0% year-over-year to 140.65%; the TTM value through Sep 2025 reached 149.98%, down 23061.0%, while the annual FY2024 figure was 179.33%, 49328.0% down from the prior year.
  • FCF Margin reached 140.65% in Q3 2025 per ASMB's latest filing, up from 174.09% in the prior quarter.
  • Across five years, FCF Margin topped out at 1027.17% in Q4 2023 and bottomed at 317.68% in Q1 2024.
  • Average FCF Margin over 4 years is 64.98%, with a median of 200.59% recorded in 2024.
  • Peak YoY movement for FCF Margin: plummeted -103270bps in 2024, then surged 8205bps in 2025.
  • A 4-year view of FCF Margin shows it stood at 301.92% in 2021, then surged by 440bps to 1027.17% in 2023, then tumbled by -101bps to 5.53% in 2024, then crashed by -2442bps to 140.65% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 140.65% in Q3 2025, 174.09% in Q2 2025, and 248.85% in Q1 2025.